Literature DB >> 19442049

Multidrug resistance through the spectacle of P-glycoprotein.

Katalin Goda1, Zsolt Bacsó, Gábor Szabó.   

Abstract

P-glycoprotein (Pgp), coded for by the mdr1 gene, is one of the ABC transporters held responsible for the phenomenon of multidrug resistance (mdr), which is reflected by a rapidly escalating failure of chemotherapy with different classes of cytotoxic agents: anthracyclins, vinca alkaloids, taxanes, epipodophylotoxins. Although overcoming resistance conveyed by Pgp alone may not be sufficient for reaching effective treatment, the abundance of observations available for this paradigmatic multidrug transporter at both in vitro and in vivo setting is a tempting ground for an updated assessment of the main currents of mdr research. In this review we attempt to help keep track of the features of Pgp-mediated drug transport that serve as the major starting points for ongoing efforts of mdr reversal. We will analyze the slowly narrowing gaps that prevail between our ever increasing understanding at the protein, cell and organism level, focusing on the molecular interactions involving Pgp.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442049     DOI: 10.2174/156800909788166493

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  39 in total

1.  Altered intracellular pH regulation in cells with high levels of P-glycoprotein expression.

Authors:  Gregory Young; Luis Reuss; Guillermo A Altenberg
Journal:  Int J Biochem Mol Biol       Date:  2010-06-03

2.  Expression of KAP1 in epithelial ovarian cancer and its correlation with drug-resistance.

Authors:  Mingqiu Hu; Xin Fu; Yanfen Cui; Shilei Xu; Yue Xu; Qiuping Dong; Lu Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 3.  Extracellular vesicles in breast cancer drug resistance and their clinical application.

Authors:  Shentong Yu; Yifang Wei; Yuqiao Xu; Yuan Zhang; Jipeng Li; Jian Zhang
Journal:  Tumour Biol       Date:  2016-01-21

4.  Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.

Authors:  Kirk D Fowers; Jindřich Kopeček
Journal:  Macromol Biosci       Date:  2012-01-25       Impact factor: 4.979

Review 5.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

Review 6.  MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer.

Authors:  Wei-xian Chen; Shan-liang Zhong; Ming-hua Ji; Meng Pan; Qing Hu; Meng-meng Lv; Zhou Luo; Jian-hua Zhao; Jin-hai Tang
Journal:  Tumour Biol       Date:  2013-11-22

7.  Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.

Authors:  Benjamin Boyerinas; Sun-Mi Park; Andrea E Murmann; Katja Gwin; Anton G Montag; Marion Zillhardt; You-Jia Hua; Ernst Lengyel; Marcus E Peter
Journal:  Int J Cancer       Date:  2011-08-16       Impact factor: 7.396

8.  Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells.

Authors:  Teng Wang; Zhen Chen; Yifei Zhu; Qiongxi Pan; Yanjun Liu; Xiaowei Qi; Linfang Jin; Jian Jin; Xin Ma; Dong Hua
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

9.  Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice.

Authors:  Qing-E Tian; Huan-De Li; Miao Yan; Hua-Lin Cai; Qin-You Tan; Wen-Yuan Zhang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

10.  Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.

Authors:  Lihua Zhao; Xianqing Jin; Youhua Xu; Yuxia Guo; Rui Liang; Zhenhua Guo; Tingfu Chen; Yanhui Sun; Xionghui Ding
Journal:  J Exp Clin Cancer Res       Date:  2010-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.